| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.23 | 3e-05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.17 | 0.005 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.1 | 0.09 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.092 | 0.1 |